Evidence map›Paper›PMID 33083246›Full record

ArticleJournal of clinical and translational hepatology2020

Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study.

Lin Fu, Jun Fei, Shen Xu, Hui-Xian Xiang, Ying Xiang, Biao Hu, Meng-Die Li, Fang-Fang Liu, Ying Li, Xiu-Yong Li and 2 more

Abstract read
In one paragraph

Article in Journal of clinical and translational hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.American journal of physiology. Gastrointestinal and liver physiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lin FuSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Jun FeiSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Shen XuSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Hui-Xian XiangSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Ying XiangSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Biao HuSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Meng-Die LiSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Fang-Fang LiuSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Ying LiUnion Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Xiu-Yong LiThe Second People's Hospital of Fuyang City, Fuyang, Anhui, China.
Hui ZhaoSecond Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
De-Xiang XuSchool of Public Health, Anhui Medical University, Hefei, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus disease 2019 (COVID-19)HepatocellularHypoproteinemialiver dysfunction (LD)Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Identifiers

PMID33083246
PMCPMC7562804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.